Positron Emission Tomography (PET) Scanners Global Market Report 2024

The positron emission tomography (pet) scanners market size has grown strongly in recent years. It will grow from $1.43 billion in 2023 to $1.51 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The expansion observed in the historical period can be attributed to factors such as advancements in radiopharmaceuticals, a rise in cancer diagnoses, the expansion of clinical applications, development in healthcare infrastructure, and a growing emphasis on early disease detection.

The positron emission tomography (pet) scanners market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be attributed to factors such as the rising incidence of neurological disorders, the integration of artificial intelligence in imaging, the intersection of oncology research and personalized medicine, expanding applications in cardiology, and the increasing aging population. Key trends in the forecast period encompass technological innovations in imaging, advancements in digital detector technology, the emergence of total-body PET scanners, expanding applications in neurology, and the development of hybrid PET/MRI systems.

The anticipated increase in cases of brain disorders is set to drive the growth of the positron emission tomography (PET) scanners market in the foreseeable future. Brain disorders, resulting from factors such as illness, genetics, or traumatic injury, impact the normal functioning of the brain. PET scans, utilizing a radioactive tracer, reveal both normal and abnormal metabolic activity in the brain. This technology is crucial for monitoring brain function, disease processes, treatment responses, and diagnosing conditions not visible in other imaging methods. For example, the Alzheimer's Association reports that as of 2022, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to reach 13.8 million by 2060. Thus, the escalating number of brain disorder cases is a key driver for the growth of the positron emission tomography (PET) scanners market.

The rising prevalence of Alzheimer's disease is expected to further boost the positron emission tomography (PET) scanners market in the coming years. Alzheimer's disease, a form of dementia impacting cognition, memory, and behavior, can be detected through PET scans, which identify abnormal amyloid protein accumulation in the brain. The Alzheimer's Association notes that in 2023, approximately 6.7 million Americans aged 65 and over were diagnosed with Alzheimer's disease, affecting about one in every nine adults aged 65 and over (10.7%). The increasing incidences of Alzheimer's disease are a significant factor propelling the positron emission tomography (PET) scanners market.

Challenges to market growth are expected due to the rise in coverage restrictions. These restrictions, driven by healthcare reimbursement policies, impact the reimbursement of PET scans based on decisions made by insurance providers, government healthcare agencies, and private payers. For example, coverage restrictions for amyloid PET scans for Alzheimer's disease are limited to clinical trial participants, allowing only one scan per lifetime. Consequently, coverage restrictions pose a challenge to the growth of the positron emission tomography (PET) scanners market.

Key players in the positron emission tomography (PET) scanner market are focusing on innovation by adopting new technologies such as Optiso Ultra Dynamic Range (UDR) detector technology to enhance their services. The Optiso UDR detector, a next-generation PET detector, employs multiple technologies for optimal performance in various count rates. Siemens Healthineers AG introduced the Biograph Vision X, a PET/CT scanner utilizing Optiso UDR detector technology to improve image quality and diagnostic accuracy. The scanner achieves higher spatial resolution and a 20% performance enhancement through the use of small LSO crystals coated by SiPMs.

In November 2021, Bruker Corporation acquired Molecules NV, a Belgium-based imaging instrumentation manufacturer. This acquisition aims to strengthen Bruker Corporation's position in translational and preclinical imaging solutions, facilitating the adoption of preclinical imaging products in biopharma companies and medical centers. Molecules NV specializes in providing PET scanners, SPECT scanners, and other imaging instruments.

Major companies operating in the positron emission tomography (pet) scanners market report are Clarity Pharmaceuticals Ltd., Hitachi Ltd., Eli Lilly and Company, Canon Medical Systems USA Inc., Toshiba Corporation, Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Phillips N.V., GE HealthCare, Perkin Elmer Inc., CMR Naviscan Corporation, Shimadzu Corporation, Neusoft Medical Systems Co. Ltd., Blue Earth Diagnostics Limited, Mediso Medical Imaging Systems, Cubresa Inc., Oncovision, Radiology Oncology Systems Inc., FMI Medical Systems Inc., Edger Systems LLC, Mediso Ltd., MR Solutions Group Ltd., Modus Medical Devices Inc., MinFound Medical Systems Co. Ltd , PETsys Electronics SA, Yangzhou Kindsway Biotech Co. Ltd., Positron Corporation, RefleXion Medical.

North America was the largest region in the positron emission tomography (PET) scanners market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (pet) scanners market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the positron emission tomography (pet) scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) scanners market consists of revenues earned by entities by providing services such as 3D imaging, detect cellular changes, diagnostic examination and nuclear medicine imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The positron emission tomography (PET) scanner market also includes sales of positron emission tomography tracers, portable PET scanners, and time-of-flight scanners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The main modalities of Positron Emission Tomography (PET) scanners include PET-CT (Positron Emission Tomography-Computed Tomography) and PET-MRI (Positron Emission Tomography-Magnetic Resonance Imaging). PET-CT refers to a scanner that combines functional data from PET scans with images of the body obtained through the detection of radiation from CT scans. Various types of detectors, such as gadolinium oxyorthosilicate, lutetium fine silicate, bismuth germanium oxide, and lutetium oxyorthosilicate, are utilized for applications in cardiology, neurology, oncology, orthopedics, urology, gastroenterology, and others. The end-users of these devices include hospitals, diagnostic centers, and other medical facilities.

The positron emission tomography (PET) scanners market research report is one of a series of new reports that provides positron emission tomography (PET) scanners market statistics, including positron emission tomography (PET) scanners industry global market size, regional shares, competitors with a positron emission tomography (PET) scanners market share, detailed positron emission tomography (PET) scanners market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) scanners industry. This positron emission tomography (PET) scanners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.